title: Proopiomelanocortin but not vasopressin or renin-angiotensin system induces resuscitative effects of central 5-HT1A activation in haemorrhagic shock in rats.
abstract: The aim of this study was to determine the effectory mechanisms: vasopressin, renin-angiotensin system and proopiomelanocortin-derived peptides (POMC), partaking in the effects of serotonin through central serotonin 1A receptor (5-HT1A) receptors in haemorrhagic shock in rats. The study was conducted on male Wistar rats. All experimental procedures were carried out under full anaesthesia. The principal experiment included a 2 hour observation period in haemorrhagic shock. Drugs used - a selective 5-HT1A agonist 8-OH-DPAT (5 μg/5 μl); V1a receptor antagonist [β-mercapto-β, β-cyclo-pentamethylenepropionyl(1),O-me-Tyr(2),Arg(8)]AVP (10 μg/kg); angiotensin type I receptor antagonist (AT1) ZD7155 (0.5 mg/kg, i.v.); angiotensin-converting-enzyme inhibitor captopril (30 mg/kg, i.v.); melanocortin type 4 (MC4) receptor antagonist HS014 (5 μg, i.c.v.). There was no influence of ZD715, captopril or blocking of the V1a receptors on changes in the heart rate (HR), mean arterial pressure (MAP), peripheral blood flow or resistance caused by the central stimulation of 5-HT1A receptors (P≥0.05). However, selective blocking of central MC4 receptors caused a slight, but significant decrease in HR and MAP (P<0.05). POMC derivatives acting via the central MC4 receptor participate in the resuscitative effects of 8-OH-DPAT. The angiotensin and vasopressin systems do not participate in these actions.
authors.affiliation: Department of Physiology, Medical University of Silesia, Zabrze, Poland. paw.sowa@gmail.com.
authors.forename: P
authors.initials: P
authors.lastname: Sowa
authors.forename: M
authors.initials: M
authors.lastname: Adamczyk-Sowa
authors.forename: K
authors.initials: K
authors.lastname: Zwirska-Korczala
authors.forename: K
authors.initials: K
authors.lastname: Pierzchala
authors.forename: D
authors.initials: D
authors.lastname: Adamczyk
authors.forename: Z
authors.initials: Z
authors.lastname: Paluch
authors.forename: M
authors.initials: M
authors.lastname: Misiolek
mesh_terms: D017371:8-Hydroxy-2-(di-n-propylamino)tetralin / Q000494:pharmacology*; D047228:Angiotensin II Type 1 Receptor Blockers / Q000494:pharmacology; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology; D000818:Animals; D062186:Arterial Pressure / Q000187:drug effects; D002216:Captopril / Q000494:pharmacology; D006339:Heart Rate / Q000187:drug effects; D008297:Male; D009287:Naphthyridines / Q000494:pharmacology; D010456:Peptides, Cyclic / Q000494:pharmacology; D011333:Pro-Opiomelanocortin / Q000502:physiology*; D051381:Rats; D017208:Rats, Wistar; D044105:Receptor, Melanocortin, Type 4 / Q000037:antagonists & inhibitors / Q000502:physiology*; D017483:Receptors, Vasopressin / Q000502:physiology; D058825:Serotonin 5-HT1 Receptor Agonists / Q000494:pharmacology*; D012771:Shock, Hemorrhagic / Q000503:physiopathology*
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; C116941:HS014 cyclic peptide; D009287:Naphthyridines; D010456:Peptides, Cyclic; D044105:Receptor, Melanocortin, Type 4; D017483:Receptors, Vasopressin; D058825:Serotonin 5-HT1 Receptor Agonists; C582098:V1a vasopressin receptor, rat; C095905:ZD 7155; D011333:Pro-Opiomelanocortin; D017371:8-Hydroxy-2-(di-n-propylamino)tetralin; D002216:Captopril